192
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Serum Free Radical Scavenging Capacity Profiles of Patients with Chronic Obstructive Pulmonary Disease

, , , , , , , ORCID Icon, & ORCID Icon show all
Pages 615-624 | Received 09 Sep 2022, Accepted 27 Mar 2023, Published online: 19 Apr 2023

References

  • The Global Initiative for Chronic Obstructive Lung disease (GOLD). Executive summary: global strategy for the diagnosis, management, and prevention of COPD; 2020. Available from: http://www.goldcopd.com. Accessed December 20, 2020.
  • MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2(1):50–60. doi:10.1513/pats.200411-056SF
  • Barnes PJ. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev. 2004;56(4):515–548. doi:10.1124/pr.56.4.2
  • Lakhdar R, Denden S, Kassab A, et al. Update in chronic obstructive pulmonary disease: role of antioxidant and metabolizing gene polymorphisms. Exp Lung Res. 2011;37(6):364–375. doi:10.3109/01902148.2011.580416
  • Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532–555. doi:10.1164/rccm.200703-456SO
  • Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138:16–27. doi:10.1016/j.jaci.2016.05.011
  • Taniguchi A, Tsuge M, Miyahara N, et al. Reactive oxygen species and antioxidative defense in chronic obstructive pulmonary disease. Antioxidants. 2021;10(10):1537. doi:10.3390/antiox10101537
  • Zinellu E, Zinellu A, Fois AG, et al. Reliability and usefulness of different biomarkers of oxidative stress in chronic obstructive pulmonary disease. Oxid Med Cell Longev. 2020;2020:4982324. doi:10.1155/2020/4982324
  • McCord JM, Wong K. Oxygen free radicals and tissue damage. Excerpta Med. 1979;65:343–351.
  • Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. Tokyo: Japan Scientific Societies Press; 1988.
  • Janzen EG. Spin trapping. Acc Chem Res. 1971;4:31–40. doi:10.1021/ar50037a005
  • Kamibayashi M, Oowada S, Kameda H, et al. Synthesis and characterization of a practically better DEPMPO-type spin trap, 5- (2,2- dimethyl-1,3-propoxy cyclophosphoryl) −5 -methyl-1-pyrroline N-oxide (CYPMPO). Free Radic Res. 2006;40:1166–1172. doi:10.1080/10715760600883254
  • Oowada S, Endo N, Kamayama H, et al. Multiple free-radical scavenging capacity in serum. J Clin Biochem Nutr. 2012;51:117–121. doi:10.3164/jcbn.11-113
  • Hirayama A, Wakusawa K, Fujioka T, et al. Simultaneous evaluation of antioxidative serum profiles facilitates the diagnostic screening of autism spectrum disorder in under-6-year-old children. Sci Rep. 2020;10(1):20602. doi:10.1038/s41598-020-77328-z
  • Kubota M, Kobayashi H, Quanjer PH, et al. Clinical pulmonary functions committee for the Japanese respiratory society, reference values for spirometry, including vital capacity, in Japanese adults calculated with the LMS method and compared with previous values. Respir Investig. 2014;52(4):242–250. doi:10.1016/j.resinv.2014.03.003
  • Goddard PR, Nicholson EM, Laszlo G, et al. Computed tomography in pulmonary emphysema. Clin Radiol. 1982;33(4):379–387. doi:10.1016/S0009-9260(82)80301-2
  • Domej W, Oettl K, Renner W. Oxidative stress and free radicals in COPD-implications and relevance for treatment. Int J Chron Obstruct Pulmon Dis. 2014;9:1207–1224. doi:10.2147/COPD.S51226
  • Ichinose M, Sugiura H, Yamagata S, et al. Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD airways. Eur Respir J. 2003;22(3):457–461. doi:10.1183/09031936.03.00052002
  • Komaki Y, Sugiura H, Koarai A, et al. Cytokine-mediated xanthine oxidase upregulation in chronic obstructive pulmonary disease’s airways. Pulm Pharmacol Ther. 2005;18:297–302. doi:10.1016/j.pupt.2005.01.002
  • Kluchova Z, Petrasova D, Joppa P, et al. The association between oxidative stress and obstructive lung impairment in patients with COPD. Physiol Res. 2007;56:51–56. doi:10.33549/physiolres.930884
  • Siu GM, Draper HH. Metabolism of malonaldehyde in vivo and in vitro. Lipids. 1982;17(5):349–355. doi:10.1007/BF02535193
  • Rahman I, Adcock IM. Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J. 2006;28:219–242. doi:10.1183/09031936.06.00053805
  • Rahman I, Morrison D, Donaldson K, et al. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med. 1996;154(4):1055–1060. doi:10.1164/ajrccm.154.4.8887607
  • Zeng M, Li Y, Jiang Y, et al. Local and systemic oxidative stress status in chronic obstructive pulmonary disease patients. Can Respir J. 2013;20(1):35–41. doi:10.1155/2013/985382
  • Sadowska AM, Luyten C, Vints AM, et al. Systemic antioxidant defences during acute exacerbation of chronic obstructive pulmonary disease. Respirology. 2006;11(6):741–747. doi:10.1111/j.1440-1843.2006.00943.x
  • Zinellu E, Zinellu A, Fois AG, et al. Oxidative stress biomarkers in chronic obstructive pulmonary disease exacerbations: a systematic review. Antioxidants. 2021;10(5):710. doi:10.3390/antiox10050710
  • Sies H. Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: oxidative eustress. Redox Biol. 2017;11:613–619. doi:10.1016/j.redox.2016.12.035